Galldiks, Norbert, Niyazi, Maximilian, Grosu, Anca L., Kocher, Martin, Langen, Karl-Josef, Law, Ian, Minniti, Giuseppe, Kim, Michelle M., Tsien, Christina, Dhermain, Frederic, Soffietti, Riccardo ORCID: 0000-0002-9204-7038, Mehta, Minesh P., Weller, Michael and Tonn, Joerg-Christian (2021). Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group. Neuro-Oncology, 23 (6). S. 881 - 894. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Full text not available from this repository.

Abstract

The management of patients with glioma usually requires multimodality treatment including surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for radiotherapy planning and follow-up after radiotherapy completion. In order to maximize the radiation dose to the tumor and to minimize toxic effects on the surrounding brain parenchyma, reliable identification of tumor extent and target volume delineation is crucial. The use of positron emission tomography (PET) for radiotherapy planning and monitoring in gliomas has gained considerable interest over the last several years, but Class I data are not yet available. Furthermore, PET has been used after radiotherapy for response assessment and to distinguish tumor progression from pseudoprogression or radiation necrosis. Here, the Response Assessment in Neuro-Oncology (RANO) working group provides a summary of the literature and recommendations for the use of PET imaging for radiotherapy of patients with glioma based on published studies, constituting levels 1-3 evidence according to the Oxford Centre for Evidence-based Medicine.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Galldiks, NorbertUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Niyazi, MaximilianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grosu, Anca L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kocher, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Langen, Karl-JosefUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Law, IanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Minniti, GiuseppeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kim, Michelle M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tsien, ChristinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dhermain, FredericUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Soffietti, RiccardoUNSPECIFIEDorcid.org/0000-0002-9204-7038UNSPECIFIED
Mehta, Minesh P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weller, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tonn, Joerg-ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-606035
DOI: 10.1093/neuonc/noab013
Journal or Publication Title: Neuro-Oncology
Volume: 23
Number: 6
Page Range: S. 881 - 894
Date: 2021
Publisher: OXFORD UNIV PRESS INC
Place of Publication: CARY
ISSN: 1523-5866
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMA; CEREBRAL RADIATION NECROSIS; CONTRAST-ENHANCED MRI; PHASE-II TRIAL; TARGET DELINEATION; PROGNOSTIC VALUE; FET-PET; GLIOBLASTOMA-MULTIFORME; DIAGNOSTIC-ACCURACYMultiple languages
Oncology; Clinical NeurologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/60603

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item